Abstract: A method of luminance lifetime imaging includes receiving incident photons at an integrated photodetector from luminescent molecules. The incident photons being received through one or more optical components of a point-of-care device. The method also includes detecting arrival times of the incident photons using the integrated photodetector. A method of analyzing blood glucose includes detecting luminance lifetime characteristics of tissue using, at least in part, an integrated circuit that detects arrival times of incident photons from the tissue. The method also includes analyzing blood glucose based upon the luminance lifetime characteristics.
Type:
Grant
Filed:
February 17, 2017
Date of Patent:
October 15, 2019
Assignee:
Tesseract Health, Inc.
Inventors:
Jonathan M. Rothberg, Keith G. Fife, David Boisvert
Abstract: A method of luminance lifetime imaging includes receiving incident photons at an integrated photodetector from luminescent molecules. The incident photons being received through one or more optical components of a point-of-care device. The method also includes detecting arrival times of the incident photons using the integrated photodetector. A method of analyzing blood glucose includes detecting luminance lifetime characteristics of tissue using, at least in part, an integrated circuit that detects arrival times of incident photons from the tissue. The method also includes analyzing blood glucose based upon the luminance lifetime characteristics.
Type:
Application
Filed:
February 17, 2017
Publication date:
August 17, 2017
Applicant:
Tesseract Health, Inc.
Inventors:
Jonathan M. Rothberg, Keith G. Fife, David Boisvert